Medisafe Discovers Mismanagement of Leading Asthma Medication

22 May 2023

Medisafe data shows that more than 25% of patients who take a leading asthma medication do so in the morning. Guidelines from the National Asthma Education and Prevention Program (NAEPP) state that this medication should only be taken at night for maximum efficacy.

Medisafe analyzed real-time, de-identified and aggregate patient-reported data gathered from thousands of patients using Medisafe and taking this leading asthma medication. The analysis showed that non-­compliant patients experience an average of three additional asthma events per month, a 13% increase, requiring the use of a rescue inhaler.

Medisafe conducted a Medsurvey through its platform and asked patients why they take this med at the wrong time and here’s how they responded:

  • 17% said morning is when they take other meds
  • 35% said morning is when they have time to take it
  • 35% said morning is when their doctor said to take it

What insights can we discover about your brand? Contact us to find out!

You may also like

Case Studies

[CASE STUDY] Pharma Leader Sees How Digital Support Amplifies Results

When faced with challenges assisting patients with access to support programs, a global pharma leader turned to Medisafe for a 

..Read More
Case Studies

Case Study: Using Human & Digital to Improve Medication Adherence

See how one manufacturer made medication management easier integrating digital engagement with human-touch patient support. The manufacturer of a leading 

..Read More

Oncology Infographic: Real-time Patient Insights from Medisafe

Highlights from the Oncology Infographic The U.S. ranks amongst the lowest in reported oncology aherence as compared to other developed 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.